Subscribe to RSS
Download PDF
DOI: 10.1055/s-0037-1613797
Bovine Protein C Inhibitor Has a Unique Reactive Site and Can Transiently Inhibit Plasmin
Publication History
Received
11 May 1999
Accepted after revision
02 September 1999
Publication Date:
11 December 2017 (online)
Summary
Protein C inhibitor (PCI) regulates the anticoagulant protein C pathway by neutralizing activated protein C and thrombin-thrombomodulin complex in the human hemostatic system. In this study, we cloned a full-length bovine PCI cDNA encoding a putative 19-residue signal peptide and a 385-residue mature protein; this showed 70.6%, 70.6%, 57.5% and 59.6% amino acid sequence homology with the human, rhesus monkey, rat and mouse PCIs, respectively. Bovine PCI mRNA (2.1 kb in size) was expressed strongly in the liver, and moderately in the kidney and testis, but not in other tissues tested. Bovine PCI has a putative reactive site peptide bond, Lys-Ser, that is different from the reactive site sequence (Arg-Ser) of other species’ PCI. We found that bovine PCI transiently inhibits bovine plasmin, but not human plasmin. Western blot analysis showed that the reactive site of bovine PCI is cleaved during the course of complex formation with bovine plasmin; degraded PCI is released from the complex gradually concomitant with the recovery of plasmin activity. These findings suggest that bovine PCI plays a role not only in the protein C pathway but also in the fibrinolytic activity of bovine hemostatic system.
Abbreviations: PCI, protein C inhibitor, Serpin, serine protease inhibitor, APC, activated protein C, TM, thrombomodulin.
-
References
- 1 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
- 2 Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 1984; 95: 187-95.
- 3 Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995; 270: 25336-9.
- 4 Meijers JC, Kanters DH, Vlooswijk RA, van EH, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-7.
- 5 Stief TW, Radtke KP, Heimburger N. Inhibition of urokinase by protein C inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor-3. Biol Chem Hoppe Seyler 1987; 368: 1427-33.
- 6 Espana F, Gilabert J, Estelles A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64: 309-20.
- 7 Hermans JM, Jones R, Stone SR. Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 1994; 33: 5440-4.
- 8 Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem 1987; 262: 611-6.
- 9 Radtke KP, Fernandez JA, Villoutreix BO, Greengard JS, Griffin JH. Characterization of a cDNA for rhesus monkey protein C inhibitor – evidence for N-terminal involvement in heparin stimulation. Thromb Haemost 1995; 74: 1079-87.
- 10 Wakita T, Hayashi T, Yuasa H, Nishioka J, Kawamura J, Suzuki K. Molecular cloning, tissue distribution and androgen regulation of rat protein C inhibitor. FEBS Lett 1998; 429: 263-8.
- 11 Zechmeister MM, Hufnagl P, Uhrin P, Xu J, Geiger M, Binder BR. Molecular cloning and tissue distribution of mouse protein C inhibitor (PCI). Immunopharmacology 1996; 32: 96-8.
- 12 Zechmeister MM, Hufnagl P, Uhrin P, Korschineck I, Binder BR, Geiger M. Molecular cloning and sequence analysis of the mouse protein C inhibitor gene. Gene 1997; 186: 61-6.
- 13 Morito F, Saito H, Suzuki K, Hashimoto S. Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2. Biochim Biophys Acta 1985; 844: 209-15.
- 14 Radtke KP, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH. Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 1994; 94: 2117-24.
- 15 Nishioka J, Ning M, Hayashi T, Suzuki K. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J Biol Chem 1998; 273: 11281-7.
- 16 Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101.
- 17 Suzuki K, Kusumoto H, Nishioka J, Komiyama Y. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor. J Biochem (Tokyo) 1990; 107: 381-8.
- 18 Ohno Y, Kato H, Morita T, Iwanaga S, Takada K, Sakakibara S, Stenflo J. A new fluorogenic peptide substrate for vitamin K-dependent blood coagulation factor, bovine protein C. J Biochem (Tokyo) 1981; 90: 1387-95.
- 19 Morita T, Kato H, Iwanaga S, Takada K, Kimura T. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem (Tokyo) 1977; 82: 1495-8.
- 20 Kato H, Adachi N, Ohno Y, Iwanaga S, Takada K, Sakakibara S. New fluorogenic peptide substrates for plasmin. J Biochem (Tokyo) 1980; 88: 183-90.
- 21 Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-63.
- 22 Suzuki K, Stenflo J, Dahlback B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-20.
- 23 Lundblad RL, Uhteg LC, Vogel CN, Kingdon HS, Mann KG. Preparation and partial characterization of two forms of bovine thrombin. Biochem Biophys Res Commun 1975; 66: 482-9.
- 24 Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989; 264: 4872-6.
- 25 Usui M, Hanamura N, Hayashi T, Kawarada Y, Suzuki K. Molecular cloning, expression and tissue distribution of canine lipopolysaccharide (LPS)-binding protein. Biochim Biophys Acta 1998; 1397: 202-12.
- 26 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-17.
- 27 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
- 28 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
- 29 Burnette WN. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203.
- 30 Burkhart WA, Moyer MB, Bailey JM, Miller CG. Electroblotting of proteins to Teflon tape and membranes for N- and C-terminal sequence analysis. Anal Biochem 1996; 236: 364-7.
- 31 Phillips JE, Cooper ST, Potter EE, Church FC. Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity. J Biol Chem 1994; 269: 16696-700.
- 32 Pratt CW, Church FC. Heparin binding to protein C inhibitor. J Biol Chem 1992; 267: 8789-94.
- 33 Cooper ST, Church FC. Reactive site mutants of recombinant protein C inhibitor. Biochim Biophys Acta 1995; 1246: 29-33.
- 34 Elisen MG, Bouma BN, Church FC, Meijer JC. Inhibition of serine proteases by reactive site mutants of protein C inhibitor (plasminogen activator inhibitor-3). Fibrinolysis & Proteolysis 1998; 12: 283-91.